Loading
Vaccine Coverage and Hesitancy · Journal article
The Lancet Regional Health - Europe · August 29, 2026
A consensus or society position rather than new primary data.
This is a policy commentary arguing that identical vaccine efficacy and safety evidence can legitimately support different national immunisation recommendations because country-specific factors—epidemiology, cost-effectiveness, societal values, and programmatic feasibility—are material to decision-making. The authors contend that while international collaboration and harmonisation efforts have merit, they cannot and should not substitute for nationally contextualized public health decision-making.
Journal article. National Immunisation Technical Advisory Groups and European Union member states making vaccine recommendations..
NITAGs consider both context-free evidence (safety, efficacy, effectiveness) and country-specific aspects including local epidemiology, cost-effectiveness, societal values, and programmatic feasibility EU-level joint clinical assessments and European Centre for Disease Prevention and Control recommendations reflect a push towards harmonisation, but identical clinical evidence can legitimately yield different national recommendations Fundamental differences in country-specific context limit harmonising national immunisation schedules across countries
NITAGs consider both context-free evidence (safety, efficacy, effectiveness) and country-specific aspects including local epidemiology, cost-effectiveness, societal values, and programmatic feasibility EU-level joint clinical assessments and European Centre for Disease Prevention and Control recommendations reflect a push towards harmonisation, but identical clinical evidence can legitimately yield different national recommendations
Clinicians and policymakers should recognise that variation in national immunisation schedules reflects legitimate differences in context and values, not deficiency; international guidelines are supportive tools, not substitutes for local evidence synthesis and decision-making.
An expert position paper on the role of National Immunisation Technical Advisory Groups in translating clinical evidence into country-specific vaccine recommendations, emphasizing the legitimacy of contextual variation.
Clinicians and policymakers should recognise that variation in national immunisation schedules reflects legitimate differences in context and values, not deficiency; international guidelines are supportive tools, not substitutes for local evidence synthesis and decision-making.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
National Immunisation Technical Advisory Groups (NITAGs) are independent expert groups issuing recommendations on the introduction and use of licensed vaccines in national programmes. They consider both context-free evidence — safety, efficacy, effectiveness — and country-specific aspects, including local epidemiology, cost-effectiveness, societal values, and programmatic feasibility. Several policy developments in the European Union (EU), including EU-level joint clinical assessments under the new Health Technology Assessment regulation and non-binding recommendations by the European Centre for Disease Prevention and Control, reflect a desire to reduce duplication of efforts but also a push towards harmonisation of immunisation recommendations across countries. Using the German NITAG as an example, we illustrate that identical clinical evidence can legitimately yield different national recommendations. Even though equitable access to vaccines across countries is desirable, fundamental differences in country-specific context limit harmonising national immunisation schedules. International collaboration and supra-national guidance can support but not substitute for national, context-sensitive public health decision-making.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.